Cowen Says PTC Therapeutics Is A Buy

By: via Benzinga
Shares of PTC Therapeutics, Inc. (NASDAQ: PTCT) rose 7 percent on Wednesday after Cowen analysts Ritu Baral and Elyse Shapiro ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.